MEI Pharma http://investor.meipharma.com/ MEI Pharma to Present at Cantor Fitzgerald Global Healthcare Conference http://investor.meipharma.com/2017-09-19-MEI-Pharma-to-Present-at-Cantor-Fitzgerald-Global-Healthcare-Conference Live Webcast from New York on September 26th Tue, 19 Sep 2017 06:00:00 -0700 http://investor.meipharma.com/2017-09-19-MEI-Pharma-to-Present-at-Cantor-Fitzgerald-Global-Healthcare-Conference MEI Pharma Announces Exclusive License Agreement with Presage Biosciences for Voruciclib, An Oral, Selective CDK Inhibitor http://investor.meipharma.com/2017-09-05-MEI-Pharma-Announces-Exclusive-License-Agreement-with-Presage-Biosciences-for-Voruciclib-An-Oral-Selective-CDK-Inhibitor Clinical-Stage Asset in Validated Class of Drugs with Demonstrated Value Tue, 05 Sep 2017 13:05:00 -0700 http://investor.meipharma.com/2017-09-05-MEI-Pharma-Announces-Exclusive-License-Agreement-with-Presage-Biosciences-for-Voruciclib-An-Oral-Selective-CDK-Inhibitor MEI Pharma Reports Fiscal Year 2017 Results http://investor.meipharma.com/2017-09-05-MEI-Pharma-Reports-Fiscal-Year-2017-Results Company Begins New Fiscal Year with $53.6 Million in Cash Tue, 05 Sep 2017 05:30:00 -0700 http://investor.meipharma.com/2017-09-05-MEI-Pharma-Reports-Fiscal-Year-2017-Results MEI Pharma to Present at Two Upcoming Investor Conferences http://investor.meipharma.com/2017-08-31-MEI-Pharma-to-Present-at-Two-Upcoming-Investor-Conferences Live Webcasts from Boston on September 7th and New York on September 8th Thu, 31 Aug 2017 06:00:00 -0700 http://investor.meipharma.com/2017-08-31-MEI-Pharma-to-Present-at-Two-Upcoming-Investor-Conferences MEI Pharma to Host Fiscal Year End Conference Call on September 5, 2017 http://investor.meipharma.com/2017-08-29-MEI-Pharma-to-Host-Fiscal-Year-End-Conference-Call-on-September-5-2017 Tue, 29 Aug 2017 06:00:00 -0700 http://investor.meipharma.com/2017-08-29-MEI-Pharma-to-Host-Fiscal-Year-End-Conference-Call-on-September-5-2017